Scientists say they have identified a way to stop a well-known signaling molecule from eroding bones and causing joint inflammation, a discovery that could potentially reverse conditions such as rheumatoid arthritis and osteoporosis. Researchers at the University of Rochester Medical Center say that changing the way a pathway known as the nuclear factor kappa B complex (NF-κB) may keep the two molecules (TNFα and RANKL) from breaking down too much bone and inflaming bones.
Read moreAn osteoporosis controversy, centered on the affordability of DXA scans, a common osteoporosis screening test, is heating up in the... Read more »
If you are here at OsteoporosisConnection.com you are aware of osteoporosis, osteopenia and some of the other metabolic bone disorders;... Read more »
Boniva®, Fosomax®, Actonel®, Forteo®… Evista®? If you’ve been diagnosed with osteoporosis or osteopenia, and changes in diet and... Read more »
Are you taking an osteoporosis medication and seeing very little improvement? If so, this is very frustrating because we do all we're... Read more »
According to Dr. Susan Ott, Professor of the University of Washington Bone Physiology Course, "Bisphosphonates are NOT APPROVED for... Read more »
Source: ADAM Encyclopedia
Thin bones Treatment The goals of osteoporosis treatment are to: Control pain from the disease Slow down or stop bone loss ... Read more »
Legislation designed to protect patient access to osteoporosis care has been introduced in the U.S. Congress. The Medicare Fracture Prevention and... Read more »
SAN FRANCISCO (Ivanhoe Broadcast News) -- About 10 million Americans suffer from osteoporosis. The condition is characterized by low bone density,... Read more »
The osteoporosis med Fosamax and other bisphosphonates have been linked to jaw bone loss, but one reader wants to know if the condition can be... Read more »
An analysis of 621 studies on more than 135,000 patients has confirmed weight-loss surgery's ability to reverse Type 2 diabetes. Researchers say that... Read more »